These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 18508998
1. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction. Matsumoto M, Yamaguchi Y, Seino Y, Hatakeyama A, Takei H, Niikura H, Ito K, Suzuki T, Sasano H, Yaegashi N, Hayashi S. Endocr Relat Cancer; 2008 Jun; 15(2):451-63. PubMed ID: 18508998 [Abstract] [Full Text] [Related]
2. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer. Yamaguchi Y, Takei H, Suemasu K, Kobayashi Y, Kurosumi M, Harada N, Hayashi S. Cancer Res; 2005 Jun 01; 65(11):4653-62. PubMed ID: 15930283 [Abstract] [Full Text] [Related]
3. Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions. Takahashi-Shiga N, Utsunomiya H, Miki Y, Nagase S, Kobayashi R, Matsumoto M, Niikura H, Ito K, Yaegashi N. Clin Cancer Res; 2009 Oct 01; 15(19):6028-34. PubMed ID: 19789322 [Abstract] [Full Text] [Related]
4. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line. Sonne-Hansen K, Lykkesfeldt AE. J Steroid Biochem Mol Biol; 2005 Jan 01; 93(1):25-34. PubMed ID: 15748829 [Abstract] [Full Text] [Related]
5. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells. Miki Y, Suzuki T, Tazawa C, Yamaguchi Y, Kitada K, Honma S, Moriya T, Hirakawa H, Evans DB, Hayashi S, Ohuchi N, Sasano H. Cancer Res; 2007 Apr 15; 67(8):3945-54. PubMed ID: 17440110 [Abstract] [Full Text] [Related]
6. Aromatase in the context of breast and endometrial cancer. A review. Jongen VH, Hollema H, Van Der Zee AG, Heineman MJ. Minerva Endocrinol; 2006 Mar 15; 31(1):47-60. PubMed ID: 16498363 [Abstract] [Full Text] [Related]
7. Estrogen signaling in cancer microenvironment and prediction of response to hormonal therapy. Hayashi S, Yamaguchi Y. J Steroid Biochem Mol Biol; 2008 Apr 15; 109(3-5):201-6. PubMed ID: 18424035 [Abstract] [Full Text] [Related]
8. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Watanabe K, Sasano H, Harada N, Ozaki M, Niikura H, Sato S, Yajima A. Am J Pathol; 1995 Feb 15; 146(2):491-500. PubMed ID: 7856758 [Abstract] [Full Text] [Related]
9. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines. Smuc T, Rizner TL. Chem Biol Interact; 2009 Mar 16; 178(1-3):228-33. PubMed ID: 19022235 [Abstract] [Full Text] [Related]
10. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism. Hanamura T, Niwa T, Nishikawa S, Konno H, Gohno T, Tazawa C, Kobayashi Y, Kurosumi M, Takei H, Yamaguchi Y, Ito K, Hayashi S. Breast Cancer Res Treat; 2013 Jun 16; 139(3):731-40. PubMed ID: 23780684 [Abstract] [Full Text] [Related]
11. Estrogen signaling and prediction of endocrine therapy. Hayashi S, Yamaguchi Y. Cancer Chemother Pharmacol; 2005 Nov 16; 56 Suppl 1():27-31. PubMed ID: 16273356 [Abstract] [Full Text] [Related]
12. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer. Smuc T, Rizner TL. Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):74-82. PubMed ID: 18930784 [Abstract] [Full Text] [Related]
13. Estrogen production via the aromatase enzyme in breast carcinoma: which cell type is responsible? Santen RJ, Santner SJ, Pauley RJ, Tait L, Kaseta J, Demers LM, Hamilton C, Yue W, Wang JP. J Steroid Biochem Mol Biol; 1997 Apr 25; 61(3-6):267-71. PubMed ID: 9365200 [Abstract] [Full Text] [Related]
14. Development of a stable dual cell-line GFP expression system to study estrogenic endocrine disruptors. Xu H, Kraus WL, Shuler ML. Biotechnol Bioeng; 2008 Dec 15; 101(6):1276-87. PubMed ID: 18980187 [Abstract] [Full Text] [Related]
15. [Tumor tissue aromatase and estrogen levels versus clinical course of endometrial cancer]. Bersteĭn LM, Chernobrovkina AE, Gamaiunova VB, Vasil'ev DA, Kovalevskiĭ AIu, Maksimov SIa, Chepik OF, Gershfel'd ED. Vopr Onkol; 2003 Dec 15; 49(1):55-9. PubMed ID: 12715371 [Abstract] [Full Text] [Related]
16. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity. Maru BS, Tobias JH, Rivers C, Caunt CJ, Norman MR, McArdle CA. Bone; 2009 Jan 15; 44(1):102-12. PubMed ID: 18976723 [Abstract] [Full Text] [Related]
17. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer. Smuc T, Rupreht R, Sinkovec J, Adamski J, Rizner TL. Mol Cell Endocrinol; 2006 Mar 27; 248(1-2):114-7. PubMed ID: 16337331 [Abstract] [Full Text] [Related]
18. Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism. Singer CF, Fink-Retter A, Gschwantler-Kaulich D, Thalhammer T, Hudelist G, Mueller R, Czerwenka K, Kubista E. Endocr Relat Cancer; 2006 Dec 27; 13(4):1101-7. PubMed ID: 17158756 [Abstract] [Full Text] [Related]
19. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12). Fournier MA, Poirier D. Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):142-5. PubMed ID: 18817841 [Abstract] [Full Text] [Related]
20. Aromatase and comparative response to its inhibitors in two types of endometrial cancer. Berstein L, Kovalevskij A, Zimarina T, Maximov S, Gershfeld E, Vasilyev D, Baisheva S, Baymakhasheva A, Thijssen JH. J Steroid Biochem Mol Biol; 2005 May 25; 95(1-5):71-4. PubMed ID: 15939586 [Abstract] [Full Text] [Related] Page: [Next] [New Search]